Diet and irritable bowel syndrome

Current Opinion in Gastroenterology

Volumn 22, Issue 2, 2006, Pages 136-139

  Alpers, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTERIAL FLORA; DIET; FOOD ALLERGY; HUMAN; IRRITABLE COLON; MULTIPLE CHEMICAL SENSITIVITY; NUTRITIONAL INTOLERANCE; REVIEW; DIET THERAPY; FOOD; STANDARD; TREATMENT OUTCOME;

FOODS, SPECIALIZED; HUMANS; IRRITABLE BOWEL SYNDROME; TREATMENT OUTCOME;

EID: 33745773137     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000208462.92136.02     Document Type: Review

References (40)

1. Gwee KA. Irritable bowel syndrome in developing countries: a disorder of civilization or colonization? Neurogastroenterol Motil 2005; 17:317-324. A review of the epidemiology of IBS on a worldwide basis.
2. Camilleri M. Mechanisms in IBS: something old, something new, something borrowed... Neurogastroenterol Motil 2005; 17:311-316. A good discussion of the present understanding of the pathophysiology of IBS.
3. Houghton LA, Atkinson W, Whitaker RP, et al. Increased platelet depleted plasma 6-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003; 52:663-670.
4. Trowell HC, Burkitt DP. The development of the concept of dietary fibre. Mol Aspects Med 1987; 9:7-15.
5. Evans JM, Fleming KC, Talley NJ, et al. Relation of colonic transit to functional bowel syndrome in older people: a population-based study. J Am Geriatr Soc 1998; 46:83-87.
6. Rees G, Davies J, Thompson R, et al. Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome. J R Soc Health 2005; 125:30-34. A small study showing only changes in stool weight after coarse wheat bran.
7. Quartero AO, Meineche-Schmidt V, Muris J, et al. Bulking agents, antispasmodics and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2005; CD003460. A good summary of the studies on fiber in IBS.
8. Whitehead WE, Crowell MD, Bosmajian L, et al. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples. Gastroenterology 1990; 98:336-340.
9. Longstreth GF, Bolus R, Naliboff B, et al. Impact of irritable bowel syndrome on patients' lives: development and psychosomatic documentation of a disease-specific measure for use in clinical trials. Eur J Gastroenterol Hepatol 2005; 17:411-420. A measurement of IBS symptoms that includes many food-related items.
10. Burden S. Dietary treatment of irritable bowel syndrome: current evidence and guidelines for future practice. Br Dietetic Assoc 2001; 14:231-241.
11. Bentley SJ, Pearson DJ, Rix KJ. Food hypersensitivity in irritable bowel syndrome. Lancet 1983; ii:295-297.
12. Farah DA, Calder I, Benson L, Mackenzie JF. Specific food intolerance: its place as a cause of gastrointestinal symptoms. Gut 1985; 26:164-168.
13. Jones AJ, McLaughlin P, Shorthouse P, Holl J. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with irritable bowel syndrome. Lancet 1982; ii:1115-1117.
14. Floch MH, Narayan R. Diet in the irritable bowel syndrome. J Clin Gastroenterol 2002; 35 (Suppl):S45-S52.
15. Lea R, Whorwell PJ. The role of food intolerance in irritable bowel syndrome. Gastroenterol Clin North Am 2005; 34:247-255. A good summary of the data on food intolerance.
16. Daboigny M, Stockbrugger RW, Azpiroz F, et al. Role of alimentation in irritable bowel syndrome. Digestion 2003; 67:225-233.
17. Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001; 48:14-19.
18. Kulig M, Bergmann R, Klettke U, et al. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999; 103:1173-1179.
19. Eigenmann PA. Future therapeutic options in food allergy. Allergy 2003; 58:1217-1223.
20. Beyer K, Teuber SS. Food allergy diagnostics: scientific and unproven procedures. Curr Opin Allergy Clin Immunol 2005; 5:261-266. A useful review of methods for determining food allergy.
21. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004;53:1459-1464. A provocative study but with a flawed design that requires confirmation.
22. Leung DY, Sampson HA, Yunginger JW, et al. Avon Longitudinal Study of Parents and Children Study Team. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348:986-993.
23. Santelmann H, Howard J Mc. Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome. Eur J Gastroenterol Hepatol 2005; 17:21-26. A review of the 'intestinal Candida syndrome'.
24. Parry S, Forgacs I. Intestinal infection and irritable bowel syndrome. Eur J Gastroenterol Hepatol 2005; 17:5-9. A review of postinfectious IBS.
25. Parry SD, Barton JR, Welfare MR. Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? Eur J Gastroenterol Hepatol 2005; 17:1071-1075. A small study that shows other factors associated with postinfectious IBS.
26. Barbara G, Stanghellini V, Brandi G, et al. Interactions between commensal bacteria and but sensorimotor function in health and disease. Am J Gastroenterol 2005; 100:2560-2568. A good review of the effects of bacteria on the human intestine.
27. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98:412-419.
28. Pimentel M, Wallace D, Hallegua D, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004; 63:450-452. The potential importance of intestinal flora is highlighted by finding symptomatic changes in a nonintestinal disorder.
29. Hawrelak JA, Myers SP. The causes of intestinal dysbiosis: a review. Altern Med Rev 2004; 9:180-197. A useful summary of the effect of diet and antibiotics on human intestinal flora.
30. Floch MH. Use of diet and probiotic therapy in the irritable bowel syndrome: Analysis of the literature. J Clin Gastroenterol 2005; 39 (Suppl 3):S243-S246. A review of the earlier studies using probiotics in IBS.
31. O'Mahoney L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541-555. A provocative and well designed study showing efficacy for one bacterium but not another.
32. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002; 5:401-412.
33. Hutton J. Cognitive behaviour therapy for irritable bowel syndrome. Eur J Gastroenterol Hepatol 2005; 17:11-14.
34. North C, Downs D, Clouse RE, et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004; 2:787-795.
35. Ninmuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes? J Psychosom Res 2001; 51:549-577.
36. Bolt HM, Kiesswetter E. Is multiple chemical sensitivity a clinically defined entity? Toxicology Lett 2002; 128:99-106.
37. Kipen HM, Fiedler N. Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge. Environ Health Perspect 2002; 110 (Suppl 4):597-599.
38. Escobar JI, Hoyos-Nervi C, Gara M. Medically unexplained physical symptoms in medical practice: a psychiatric perspective. Environ Health Perspect 2002; 110 (Suppl 4):631-636.
39. Miller CS. The compelling anomaly of chemical intolerance. Ann N Y Acad Sci 2001; 933:1-23.
40. Clauw DJ. Potential mechanisms in chemical intolerance and related conditions. Ann N Y Acad Sci 2001; 933:235-253.